Osteosarcoma in New Zealand: An outcome study comparing survival rates between 1981-1987 and 1994-1999

New Zealand Medical Journal

Volumn 119, Issue 1242, 2006, Pages

  Curry, Hamish ^a   Horne, Geoffrey ^b   Devane, Peter ^b   Tobin, Helen ^c  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b WELLINGTON HOSPITAL   (New Zealand)

^c HUTT HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURVIVAL; COHORT ANALYSIS; DATA ANALYSIS; HUMAN; INFORMATION RETRIEVAL; MEDICAL LITERATURE; NEW ZEALAND; ORTHOPEDIC SURGERY; OSTEOSARCOMA; OUTCOME ASSESSMENT; REVIEW; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR LOCALIZATION; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BONE TUMOR; CHILD; COMPARATIVE STUDY; FEMALE; INFANT; MALE; MIDDLE AGED; MORTALITY; NEWBORN; PRESCHOOL CHILD; REGISTER; SEX RATIO; SURVIVAL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEW ZEALAND; OSTEOSARCOMA; OUTCOME ASSESSMENT (HEALTH CARE); REGISTRIES; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 33749351085     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. World Health Organization classification of tumours, pathology and genetics of tumours of soft tissue and bone. Fletcher CDM, Unni KK, Mertens F, eds. Lyon: IARC Press; 2002 p264-85.
2. Kotz R, Dominkus M, Zettl T, et al. Advances in bone tumour treatment in 30 years with respect to survival and limb salvage. A single institution experience. Int Orthop. 2002;26:197-202.
3. Mills HJ, Horne G, Devane P. Osteosarcoma in New Zealand 1981-7: an overview. N Z Med J. 1995;108:458-9.
4. Grimer RJ, Taminiau AM, Cannon SR; Surgical Subcommittee on behalf of the European Osteosarcoma Intergroup. Surgical outcomes in osteosarcoma. J Bone Joint Surg Br. 2002;84:395-400.
5. Hauben EI, Weeden S, Pringle J, et al. Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup. Eur J Cancer. 2002;38:1218-25.
6. Souhami RL, Craft AW, Van der Eijken, JW, et al. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet. 1997;350:911-7.
7. Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002;20:776-90.
8. Bacci G, Ferrari S, Lari S, et al. Osteosarcoma of the limb. Amputation or limb salvage in patients treated by neoadjuvant chemotherapy. J Bone Joint Surg Br. 2002;84:88-92.
9. Bacci G, Briccoli A, Ferrari S, et al. Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol. Eur J Cancer. 2001;37:2030-9.
10. Carsi B, Rock MG. Primary osteosarcoma in adults older than 40 years. Clin Orthop Relat Res. 2002;(397):53-61.
11. Kager L, Zoubek A, Potschger U, et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol. 2003;21:2011-8.
12. Mialou V, Philip T, Perol D, et al. Metastatic osteosarcoma: prognosis factors and treatment. Bull Cancer. 2001;88:1129-35.